FDA outside experts face stricter rules on industry ties

08/4/2008 | Hill, The

The FDA announced that it will not let outside experts serve on an advisory panel if they or their immediate relatives have a financial stake of $50,000 or more in a drug or medical-device firm being reviewed. The restriction is part of the agency's new policies that address concerns about its independent advisers' industry relationships, including objectivity and conflicts of interest.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ